An In-Depth Overview of CGRP Inhibitors & Therapeutic Implementation to Improve Patient Outcomes
Program Overview
This CME activity will review recent advances in the improvement CGRP Inhibitors & Therapeutic Implementation as presented at the American Headache Society (AHS) 2019 Philadelphia, PA. The expert faculty will discuss the immunologic and pathogenic mechanisms of CGRP as well as strategies for implementation of novel CGRP inhibitors into patient-specific treatments. The faculty will also analyze safety, efficacy, ...View Course
Clinical Updates for the Optimal Management of Patients with Inflammatory Bowel Disease
Program Overview
This CME activity will review recent advances in the management of patients with Inflammatory Bowel Disease (IBD) as presented at the Digestive Disease Week (DDW) 2019 in San Diego, CA. The expert faculty will discuss the science of the inflammatory cascade as well as review recent clinical trial data for IBD treatments. The faculty will also discuss strategies ...View Course
An In-Depth Analysis of Asthma and Emerging Pharmacotherapies for Effective Patient Management
Program Overview
This CME program was derived from content presented at the Eastern Pulmonary Conference 2019 Annual Meeting in Palm Beach, Florida. The expert faculty, Dr. Sidney Braman, will review the pathophysiology and disease burden of asthma to improve patient management. Next, he will delve into the subtypes of asthma and analyze clinical data of novel pharmacotherapies to determine treatment ...View Course
Advances in the Management and Treatment of Patients with Previously-Treated Non-Small Cell Lung Cancer
Program Overview
This CME program was derived from content presented at the Eastern Pulmonary Conference 2019 Annual Meeting in Palm Beach, Florida. Drs. Charles Powell and Julie Barta will review the most recent discoveries about non-small cell lung cancer (NSCLC) tumor microenvironment as well as strategies for the treatment and management of NSCLC. The expert faculty will review strategies to ...View Course
New Therapeutic Options for Acute and Chronic Hyperkalemia
Program Overview
This CME/CE program, derived from content presented at the 2019 American Heart Association Scientific Sessions in Philadelphia, Pennsylvania, will highlight new therapeutic options for acute and chronic hyperkalemia. The expert faculty, led by Dr. Charles V. Pollack, Jr., will first provide an introduction and state of the science of hyperkalemia, including risk assessment and disease burden. Recent trial ...View Course
Incorporating Innovative Pharmaceuticals to Achieve Optimal Outcomes in Patients with Breast Cancer
Program Overview
This continuing education program will highlight recent advances in the treatment and management of breast cancer, with a focus on HER2-targeted therapy. The expert faculty will review the current treatment landscape for both early stage and metastatic breast cancer. Recent clinical trial data of emerged and emerging agents, particularly best practices for optimizing HER2-targeted therapy continuing into the ...View Course
Achieving Improved Outcomes in Children and Infants with Spinal Muscular Atrophy
Program Overview
This CME/CE activity is derived from content presented at the American Academy of Pediatrics National Conference and Exhibition in New Orleans, LA. The program will outline best practices for achieving improved outcomes in children and infants with spinal muscular atrophy (SMA). The faculty will first delve into the pathophysiology, genetics and diagnostics of SMA, as well as disease ...View Course
Reducing the Risk of Relapse in Patients with Relapsing Forms of Multiple Sclerosis
Program Overview
This CME program will highlight recent advances in the treatment and management of multiple sclerosis (MS), with a focus on best practices for reducing risk in patients with relapsing forms of MS. The expert faculty will analyze current guidelines and recommendations, highlighting the definitions of MS activity, progression, and worsening. Various emerged and emerging agents for the treatment ...View Course
Advances in the Diagnosis and Treatment of Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults
Program Overview
This CME program is derived from content presented at the Florida Society of Neurology 2019 held in Orlando, Florida on September 13, 2019. The expert faculty will discuss the importance of patient screening, accurate diagnosing, and cross-disciplinary approaches for the management of Hereditary Transthyretin-Mediated Amyloidosis (hATTR). This includes a review the most recent clinical trial data for the ...View Course
Clinical Update of Disease Modifying Therapies for the Management of Parkinson’s Disease
Program Overview
This CME program is derived from content presented at the Florida Society of Neurology 2019 held in Orlando, Florida on September 13, 2019. The expert faculty will provide an overview of current and emerging therapies for the treatment of Parkinson’s disease. This includes an a review of proper patient screenings and novel therapeutic approaches. The faculty will also ...View Course
